Sakaguchi, M., T. Yamanaka, K. Ikeda, Y. Sano, H. Fujita, T. Miura, and S. Inouye. 1997. IgE-mediated systemic reactions to gelatin included in the varicella vaccine. Journal of Allergy and Clinical Immunology 99(2):263-264.

Sauerbrei, A., E. Rubtcova, P. Wutzier, D. Scott Schmid, and V. N. Loparev. 2004. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster. Journal of Clinical Microbiology 42(12):5604-5608.

Sauerbrei, A., B. Uebe, and P. Wutzler. 2003. Molecular diagnosis of zoster post varicella vaccination. Journal of Clinical Virology 27(2):190-199.

Schwab, J., and M. Ryan. 2004. Varicella zoster virus meningitis in a previously immunized child. Pediatrics 114(2):e273-e274.

Shah, K. N., P. J. Honig, and A. C. Yan. 2007. “Urticaria multiforme”: A case series and review of acute annular urticarial hypersensitivity syndromes in children. Pediatrics 119(5):e1117-e1183.

Sharrar, R. G., P. LaRussa, S. A. Galea, S. P. Steinberg, A. R. Sweet, R. M. Keatley, M. E. Wells, W. P. Stephenson, and A. A. Gershon. 2001. The postmarketing safety profile of varicella vaccine. Vaccine 19(7-8):916-923.

Shiow, L. R., K. Paris, M. C. Akana, J. G. Cyster, R. U. Sorensen, and J. M. Puck. 2009. Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a coronin-1a mutation and a chromosome 16p11.2 deletion. Clinical Immunology 131(1):24-30.

Slordahl, S. H., S. O. Lie, and D. Wiger. 1984. Vaccination of immunocompromised children against varicella [in Norwegian]. Tidsskrift for Den Norske Laegeforening 104(30): 2086-2089.

Slordahl, S. H., D. Wiger, T. Stromoy, M. Degre, E. Thorsby, and S. O. Lie. 1985. Vaccination of children with malignant disease against varicella. Postgraduate Medical Journal 61(Suppl. 4):85-92.

Sorensen, G. V., J. Helgestad, and S. Rosthoj. 2009. Varicella-associated morbidity in children undergoing chemotherapy for acute lymphoblastic leukaemia [in Danish]. Ugeskrift for Laeger 171(46):3354-3359.

Souayah, N., S. Ajroud-Driss, H. W. Sander, T. H. Brannagan, A. P. Hays, and R. L. Chin. 2009. Small fiber neuropathy following vaccination for rabies, varicella or Lyme disease. Vaccine 27(52):7322-7325.

Sugino, H., R. Tsukino, E. Miyashiro, T. Dezawa, K. Shinohara, S. Uemura, and M. Koike. 1984. Live varicella vaccine: Prevention of nosocomial infection and protection of high risk infants from varicella infection. Biken Journal 27(2-3):63-65.

Sunaga, Y., A. Hikima, T. Ostuka, and A. Morikawa. 1995. Acute cerebellar ataxia with abnormal MRI lesions after varicella vaccination. Pediatric Neurology 13(4):340-342.

Suvatte, V., C. Wasi, and U. Kositanont. 1985. Live attenuated varicella vaccination in immunocompromised children. Asian Pacific Journal of Allergy and Immunology 3(1):16-22.

Takahashi, M., H. Kamiya, K. Baba, Y. Asano, T. Ozaki, and K. Horiuchi. 1985. Clinical experience with Oka live varicella vaccine in Japan. Postgraduate Medical Journal 61(Suppl. 4):61-67.

Takahashi, M., Y. Okuno, T. Otsuka, J. Osame, A. Takamizawa, T. Sasada, and T. Kubo. 1975. Development of a live attenuated varicella vaccine. Biken Journal 18(1):25-33.

Takahashi, M., T. Otsuka, Y. Okuno, Y. Asano, and T. Yazaki. 1974. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2(7892):1288-1290.

Uebe, B., A. Sauerbrei, S. Burdach, and G. Horneff. 2002. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child. European Journal of Pediatrics 161(8):442-444.

Ueda, K., I. Yamada, M. Goto, T. Nanri, H. Fukuda, M. Katsuta, T. Otsuka, and M. Takahashi. 1977. Use of a live varicella vaccine to prevent the spread of varicella in handicapped or immunosuppressed children including MCLS (muco-cutaneous lymphnode syndrome) patients in hospitals. Biken Journal 20(3-4):117-123.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement